Diverchim
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6 Rue Du Noyer, Roissy-en-France, Ile-de...Phone Number
+33 130119550Website
www.diverchim.comRevenue
$6.5 MillionIndustry
About Diverchim
Is Diverchim your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Diverchim is spiking on competitors!
Diverchim, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Diverchim has new funding data
Congratulate Masked Content for being promoted to Masked Content at Diverchim
Product Launch: Get notified when Diverchim launches new products
Click to see if Diverchim had a recent Job posting/layoffs
Earning: See what the market has to say on Diverchim recently announced quarterly report
Check if Diverchim has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Diverchim as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Diverchim is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Diverchim is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Diverchim.
Diverchim Tech Stack
A closer look at the technologies used by Diverchim
Diverchim News & Media
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Diverchim
DIVERCHIM CDMO is a prominent French Contract Development and Manufacturing Organization (CDMO) that specializes in high-value small molecule drug substances for the pharmaceutical, cosmetics, and specialty chemicals industries. The company has extensive expertise in orphan drugs, rare diseases, emergency medications, and radiopharmaceutical precur... Read More